
Fin d'année 30 Avril 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 0.709 | 0.009 | 5.667 | 0.904 | 30.965 | -25.225 | 8.675 | -2.08 |
Return on Equity (%) | 0.804 | 0.01 | 5.88 | 0.932 | 33.987 | -30.164 | 10.403 | -2.435 |
Return on Invested Capital (%) | -6.045 | -0.115 | 8.948 | -0.197 | 3.07 | 0.772 | 0.522 | 0.888 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 43.109 | 48.023 | 52.216 | 53.159 | 75.349 | 56.268 | 62.601 | 60.843 |
Earnings Per Share | 0.374 | 0.005 | 2.977 | 0.526 | 22.618 | -20.219 | 5.95 | -1.499 |
Cash Per Share | N/A | N/A | N/A | 0.001 | N/A | N/A | N/A | 0.001 |
Working Capital Per Share | -5.815 | -2.167 | -1.599 | -1.598 | -11.242 | -14.634 | -9.294 | -11.762 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | 0.599 | 0.238 | 2.979 | 0.556 | 22.618 | -20.219 | 5.95 | -1.463 |
Fin d'année 30 Avril 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 5,35M | 4,85M | 4,75M | 4,15M | 3,82M | 3,7M | 4,02M | 4,04M |
Fin d'année 30 Avril 2024 | ||||||||
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | |||||||
Return on Assets (%) | N/A | |||||||
Return on Equity (%) | N/A | |||||||
Return on Invested Capital (%) | N/A | |||||||
Operating Margin (%) | N/A | |||||||
Net Profit Margin (%) | N/A | |||||||
Sales Per Share | N/A | |||||||
Book Value Per Share | N/A | |||||||
Earnings Per Share | N/A | |||||||
Cash Per Share | N/A | |||||||
Working Capital Per Share | N/A | |||||||
Operating Profit Per Share | N/A | |||||||
EBIT Per Share | N/A | |||||||
EBITDA Per Share | N/A | |||||||
Free Cash Flow Per Share | N/A | |||||||
Current Ratio | N/A | |||||||
Quick Ratio | N/A | |||||||
Inventory Turnover (Days) | N/A |
Capitalisation boursière | 273,28M |
Ratio cours/bénéfice | -45,11 |
Ratio prix/ventes | 263,81 |
Ratio prix/liquidités | 45,09k |
Ratio prix/valeur comptable | 1,11 |
Rendement de dividende | 5,91% |
Actions en circulation | 4,04M |
Volume moyen (1 semaine) | 5,01k |
Volume moyen (1 mois) | 5,94k |
Variation sur 52 semaines | 4,99% |
Plus haut sur 52 semaines | 72,8399 |
Plus bas sur 52 semaines | 59,3199 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales